Objective: The present study aims to understand perceptions of deep brain stimulation (DBS) for severe obsessive-compulsive disorder (OCD) in adolescents among two groups: parents of children with a history of OCD and adults with a history of OCD. Methods: Two hundred sixty participants completed a questionnaire exploring their treatment history, relevant symptom severity, DBS knowledge, and DBS attitudes using an acceptability scale and a series of statements indicating levels of willingness or reluctance to consider DBS for adolescents with severe OCD or severe epilepsy. Results: Overall, participants found DBS to be fairly acceptable for adolescents with severe OCD, with 63% reporting at least 7/10 on a 0-10 acceptability Likert scale. Respondents were more willing to consider DBS for epilepsy than for OCD. Several factors were associated with greater willingness to consider DBS for OCD, including familiarity with DBS, the presence of suicidal thoughts, assurances of daily functioning improvements, and assurances of substantial symptom reduction. Concerns about safety, personality changes, and long-term effects on the body were associated with greatest reluctance to consider DBS for OCD. Conclusions: Our findings support the importance of increasing parents' familiarity with DBS, monitoring factors participants identified as most important to their DBS perceptions in future DBS research, and communicating benefits and risks clearly. We also highlight the need for further research on perceptions of DBS for severe and refractory OCD in adolescents.
Objective: The present study aims to understand perceptions of deep brain stimulation (DBS) for severe obsessive-compulsive disorder (OCD) in adolescents among two groups: parents of children with a history of OCD and adults with a history of OCD. Methods: Two hundred sixty participants completed a questionnaire exploring their treatment history, relevant symptom severity, DBS knowledge, and DBS attitudes using an acceptability scale and a series of statements indicating levels of willingness or reluctance to consider DBS for adolescents with severe OCD or severe epilepsy. Results: Overall, participants found DBS to be fairly acceptable for adolescents with severe OCD, with 63% reporting at least 7/10 on a 0-10 acceptability Likert scale. Respondents were more willing to consider DBS for epilepsy than for OCD. Several factors were associated with greater willingness to consider DBS for OCD, including familiarity with DBS, the presence of suicidal thoughts, assurances of daily functioning improvements, and assurances of substantial symptom reduction. Concerns about safety, personality changes, and long-term effects on the body were associated with greatest reluctance to consider DBS for OCD. Conclusions: Our findings support the importance of increasing parents' familiarity with DBS, monitoring factors participants identified as most important to their DBS perceptions in future DBS research, and communicating benefits and risks clearly. We also highlight the need for further research on perceptions of DBS for severe and refractory OCD in adolescents.
Entities:
Keywords:
DBS; adolescents; deep brain stimulation; epilepsy; neuroethics; obsessive-compulsive disorder
Authors: Eric A Storch; Sandra L Cepeda; Eric Lee; Sarah L V Goodman; Anthony D Robinson; Alessandro S De Nadai; Sophie C Schneider; Sameer A Sheth; Laura Torgerson; Gabriel Lázaro-Muñoz Journal: J Child Adolesc Psychopharmacol Date: 2019-11-07 Impact factor: 2.576
Authors: Emily A Holmes; Ata Ghaderi; Catherine J Harmer; Paul G Ramchandani; Pim Cuijpers; Anthony P Morrison; Jonathan P Roiser; Claudi L H Bockting; Rory C O'Connor; Roz Shafran; Michelle L Moulds; Michelle G Craske Journal: Lancet Psychiatry Date: 2018-03 Impact factor: 27.083
Authors: Naomi A Fineberg; Bernardo Dell'Osso; Umberto Albert; Giuseppe Maina; Daniel Geller; Lior Carmi; Nick Sireau; Susanne Walitza; Giacomo Grassi; Stefano Pallanti; Eric Hollander; Vlasios Brakoulias; Jose M Menchon; Donatella Marazziti; Konstantinos Ioannidis; Annemieke Apergis-Schoute; Dan J Stein; Danielle C Cath; Dick J Veltman; Michael Van Ameringen; Leonardo F Fontenelle; Roseli G Shavitt; Daniel Costa; Juliana B Diniz; Joseph Zohar Journal: Eur Neuropsychopharmacol Date: 2019-02-14 Impact factor: 4.600
Authors: David Lawrence; Jennifer Hafekost; Sarah E Johnson; Suzy Saw; William J Buckingham; Michael G Sawyer; John Ainley; Stephen R Zubrick Journal: Aust N Z J Psychiatry Date: 2015-12-06 Impact factor: 5.744